Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Ramucirumab Intravenous
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Ranexa
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Ranibizumab
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Ranibizumab Intraocular
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Ranibizumab ophthalmic
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Ranitidine
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Ranitidine Capsule
- Ramucirumab Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Ramucirumab Intravenous-Omeclamox-Pak
- Ramucirumab Intravenous-Omega-3 Fatty Acid Capsules
- Ramucirumab Intravenous-Omega-3 Fatty Acids
- Ramucirumab Intravenous-Omega-3 polyunsaturated fatty acids
- Ramucirumab Intravenous-Omega-3-acid ethyl esters